Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 95 (RN7SKP95) is a pseudogene related to RN7SK, a small nuclear non-coding RNA (~330 nucleotides) that is ubiquitously expressed and transcribed by RNA polymerase III[1][2][3]. The pseudogene itself is not known to produce a functional transcript or play a biological role. The parental gene, RN7SK, is involved in the regulation of transcriptional elongation via interaction with factors such as P-TEFb and has been studied for its role in processes such as cell cycle regulation, transcription elongation, and cell differentiation[1][2][3]. There is no evidence to suggest that RN7SKP95 has a direct role in disease, drug interactions, or acts as a molecular target.
Not applicable (pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 95 (RN7SKP95).